TESSENDERLO GROUP (TESB.BR) Fundamental Analysis & Valuation

EBR:TESB • BE0003555639

Current stock price

21.35 EUR
-0.15 (-0.7%)
Last:

This TESB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TESB.BR Profitability Analysis

1.1 Basic Checks

  • In the past year TESB has reported negative net income.
  • TESB had a positive operating cash flow in the past year.
  • TESB had positive earnings in 4 of the past 5 years.
  • TESB had a positive operating cash flow in each of the past 5 years.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • TESB's Return On Assets of -3.07% is on the low side compared to the rest of the industry. TESB is outperformed by 63.89% of its industry peers.
  • TESB has a worse Return On Equity (-4.80%) than 61.11% of its industry peers.
  • TESB has a Return On Invested Capital of 2.79%. This is comparable to the rest of the industry: TESB outperforms 50.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TESB is below the industry average of 6.88%.
Industry RankSector Rank
ROA -3.07%
ROE -4.8%
ROIC 2.79%
ROA(3y)0.72%
ROA(5y)4.1%
ROE(3y)1.04%
ROE(5y)7.19%
ROIC(3y)2.84%
ROIC(5y)6.39%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • TESB has a Operating Margin (2.82%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of TESB has declined.
  • Looking at the Gross Margin, with a value of 19.03%, TESB is doing worse than 69.44% of the companies in the same industry.
  • TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.82%
PM (TTM) N/A
GM 19.03%
OM growth 3Y-39.02%
OM growth 5Y-23.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-7.25%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

7

2. TESB.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TESB is destroying value.
  • The number of shares outstanding for TESB has been reduced compared to 1 year ago.
  • Compared to 5 years ago, TESB has more shares outstanding
  • TESB has a better debt/assets ratio than last year.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.02 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.02, TESB is in line with its industry, outperforming 40.28% of the companies in the same industry.
  • The Debt to FCF ratio of TESB is 2.68, which is a good value as it means it would take TESB, 2.68 years of fcf income to pay off all of its debts.
  • TESB's Debt to FCF ratio of 2.68 is amongst the best of the industry. TESB outperforms 88.89% of its industry peers.
  • TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • TESB has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. TESB outperforms 84.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.68
Altman-Z 2.02
ROIC/WACC0.38
WACC7.4%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that TESB has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.08, TESB is in the better half of the industry, outperforming 65.28% of the companies in the same industry.
  • TESB has a Quick Ratio of 1.12. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of TESB (1.12) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.12
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. TESB.BR Growth Analysis

3.1 Past

  • The earnings per share for TESB have decreased strongly by -294.77% in the last year.
  • The Revenue has been growing slightly by 4.36% in the past year.
  • Measured over the past years, TESB shows a quite strong growth in Revenue. The Revenue has been growing by 9.72% on average per year.
EPS 1Y (TTM)-294.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-306.78%
Revenue 1Y (TTM)4.36%
Revenue growth 3Y2.21%
Revenue growth 5Y9.72%
Sales Q2Q%1.36%

3.2 Future

  • Based on estimates for the next years, TESB will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.56% on average per year.
  • Based on estimates for the next years, TESB will show a small growth in Revenue. The Revenue will grow by 2.98% on average per year.
EPS Next Y3.7%
EPS Next 2Y16.73%
EPS Next 3Y14.56%
EPS Next 5YN/A
Revenue Next Year3.04%
Revenue Next 2Y3.48%
Revenue Next 3Y2.98%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

3

4. TESB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • TESB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • TESB is valuated correctly with a Price/Forward Earnings ratio of 16.65.
  • TESB's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. TESB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.65
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • 97.22% of the companies in the same industry are more expensive than TESB, based on the Enterprise Value to EBITDA ratio.
  • 75.00% of the companies in the same industry are more expensive than TESB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.97
EV/EBITDA 3.75
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TESB does not grow enough to justify the current Price/Earnings ratio.
  • TESB's earnings are expected to grow with 14.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.73%
EPS Next 3Y14.56%

4

5. TESB.BR Dividend Analysis

5.1 Amount

  • TESB has a Yearly Dividend Yield of 2.49%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of TESB has falen by -22.22%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • TESB's Dividend Yield is a higher than the industry average which is at 2.24.
  • Compared to an average S&P500 Dividend Yield of 1.82, TESB pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.49%

5.2 History

  • The dividend of TESB has a limited annual growth rate of 4.01%.
Dividend Growth(5Y)4.01%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • The earnings of TESB are negative and hence is the payout ratio. TESB will probably not be able to sustain this dividend level.
  • TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-55.49%
EPS Next 2Y16.73%
EPS Next 3Y14.56%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

TESB.BR Fundamentals: All Metrics, Ratios and Statistics

TESSENDERLO GROUP

EBR:TESB (4/30/2026, 7:00:00 PM)

21.35

-0.15 (-0.7%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Industry Strength52.03
Industry Growth62
Earnings (Last)04-01
Earnings (Next)N/A
Inst Owners5.48%
Inst Owner ChangeN/A
Ins Owners68.68%
Ins Owner ChangeN/A
Market Cap1.26B
Revenue(TTM)2.76B
Net Income(TTM)-81.10M
Analysts76.36
Price Target26.01 (21.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.49%
Yearly Dividend0.75
Dividend Growth(5Y)4.01%
DP-55.49%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.56%
PT rev (3m)-5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-32.2%
EPS NY rev (3m)-27.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.15%
Revenue NY rev (3m)-2.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.65
P/S 0.46
P/FCF 16.97
P/OCF 5.59
P/B 0.75
P/tB 0.85
EV/EBITDA 3.75
EPS(TTM)-1.33
EYN/A
EPS(NY)1.28
Fwd EY6.01%
FCF(TTM)1.26
FCFY5.89%
OCF(TTM)3.82
OCFY17.9%
SpS46.78
BVpS28.61
TBVpS25.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.07%
ROE -4.8%
ROCE 3.72%
ROIC 2.79%
ROICexc 3.02%
ROICexgc 3.39%
OM 2.82%
PM (TTM) N/A
GM 19.03%
FCFM 2.69%
ROA(3y)0.72%
ROA(5y)4.1%
ROE(3y)1.04%
ROE(5y)7.19%
ROIC(3y)2.84%
ROIC(5y)6.39%
ROICexc(3y)3.1%
ROICexc(5y)7.32%
ROICexgc(3y)3.58%
ROICexgc(5y)8.19%
ROCE(3y)3.79%
ROCE(5y)8.52%
ROICexgc growth 3Y-39.81%
ROICexgc growth 5Y-21.61%
ROICexc growth 3Y-40.4%
ROICexc growth 5Y-21.36%
OM growth 3Y-39.02%
OM growth 5Y-23.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-7.25%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.68
Debt/EBITDA 0.31
Cap/Depr 56.22%
Cap/Sales 5.48%
Interest Coverage 7.79
Cash Conversion 65.01%
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 1.12
Altman-Z 2.02
F-Score5
WACC7.4%
ROIC/WACC0.38
Cap/Depr(3y)77.15%
Cap/Depr(5y)77.84%
Cap/Sales(3y)6.13%
Cap/Sales(5y)5.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-306.78%
EPS Next Y3.7%
EPS Next 2Y16.73%
EPS Next 3Y14.56%
EPS Next 5YN/A
Revenue 1Y (TTM)4.36%
Revenue growth 3Y2.21%
Revenue growth 5Y9.72%
Sales Q2Q%1.36%
Revenue Next Year3.04%
Revenue Next 2Y3.48%
Revenue Next 3Y2.98%
Revenue Next 5YN/A
EBIT growth 1Y22.1%
EBIT growth 3Y-37.67%
EBIT growth 5Y-15.79%
EBIT Next Year221.47%
EBIT Next 3Y57.58%
EBIT Next 5YN/A
FCF growth 1Y-51.31%
FCF growth 3Y-4.9%
FCF growth 5Y-16.41%
OCF growth 1Y-32.26%
OCF growth 3Y4.15%
OCF growth 5Y-4.38%

TESSENDERLO GROUP / TESB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


Can you provide the valuation status for TESSENDERLO GROUP?

ChartMill assigns a valuation rating of 3 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Overvalued.


What is the profitability of TESB stock?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 2 / 10.


What is the financial health of TESSENDERLO GROUP (TESB.BR) stock?

The financial health rating of TESSENDERLO GROUP (TESB.BR) is 7 / 10.


What is the expected EPS growth for TESSENDERLO GROUP (TESB.BR) stock?

The Earnings per Share (EPS) of TESSENDERLO GROUP (TESB.BR) is expected to grow by 3.7% in the next year.